Veronika Sexl

Veronika Sexl (born February 27, 1966) is an Austrian pharmacologist and toxicologist with interests in cancer research.^[1] Since March 1, 2023 she is rector of the University of Innsbruck.^[2]

Her main research areas include: comparative and translational medicine using transgenic animals and human patient samples as disease models; NK cell mediated tumor surveillance with a focus on leukemia; signaling pathways involved in hematopoiesis and leukemogenesis with a focus on JAK-STAT signaling and on the novel role of CDK6 as transcriptional regulator.^[1]

Awards

2004: Billroth Award of the Austrian Medical Association^[1]
2005: Novartis Prize for Medicine^[1]
2006: Alois Sonnleitner Prize of the Austrian Academy of Sciences (ÖAW)^[1]
2008" “Major Central European Prize of the City of Vienna Fund for innovative interdisciplinary cancer research” - Major Award for Cancer Research of the Vienna Fund^[1]
2015: Elected member of the Austrian Academy of Sciences (OAW)^[1]
2017: Award for Medical Sciences of the City of Vienna^[1]

References

^ ^a ^b ^c ^d ^e ^f ^g ^h Curriculum Vitae of Veronika Sexl (retrieved July 14, 2024)
^ Neues Rektor innenteam im Amt

[cv-1] ^ ^a ^b ^c ^d ^e ^f ^g ^h Curriculum Vitae of Veronika Sexl (retrieved July 14, 2024)

[2] Neues Rektor innenteam im Amt

[1]

[2]